Phase II Study of Asparagine-Glycine-Arginine-Human Tumor...

Journal of Clinical Oncology 2010 / 05 Vol. 28; Iss. 15

Phase II Study of Asparagine-Glycine-Arginine-Human Tumor Necrosis Factor  , a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Gregorc, V., Zucali, P. A., Santoro, A., Ceresoli, G. L., Citterio, G., De Pas, T. M., Zilembo, N., De Vincenzo, F., Simonelli, M., Rossoni, G., Spreafico, A., Grazia Vigano, M., Fontana, F., De Braud
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2009.27.3649
Date:
May, 2010
File:
PDF, 231 KB
english, 2010
Conversion to is in progress
Conversion to is failed